• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌患者在镓-前列腺特异性膜抗原(Ga-PSMA)、碳-胆碱(C-choline)和氟-脱氧葡萄糖(F-FDG)PET/CT检查中神经节的异质性代谢模式

The Heterogeneous Metabolic Patterns of Ganglia in Ga-PSMA, C-choline, and F-FDG PET/CT in Prostate Cancer Patients.

作者信息

Shi Yiping, Wu Jian Guo, Xu Lian, Zhu Yinjie, Wang Yining, Huang Gan, Liu Jianjun, Chen Ruohua

机构信息

Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Department of Nuclear Medicine, Second Affiliated Hospital, Nanchang University, Nanchang, China.

出版信息

Front Oncol. 2021 Apr 23;11:666308. doi: 10.3389/fonc.2021.666308. eCollection 2021.

DOI:10.3389/fonc.2021.666308
PMID:33968772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8103210/
Abstract

PURPOSE

Studies have indicated that PSMA-positive ganglia represent a diagnostic pitfall for nuclear medicine physicians. No studies have described choline and FDG uptake in ganglia, which may be a source of misdiagnosis. Herein, we described the percentage and uptake pattern of Ga-PSMA, C-choline and F-FDG PET/CT in ganglia and evaluated the heterogeneous metabolic patterns of ganglia to differentiate from lymph node metastases (LNM).

METHODS

Thirty-nine patients who underwent C-choline PET/CT and 120 patients who underwent Ga-PSMA PET/CT and F-FDG PET/CT were retrospectively analyzed. The prevalence of PSMA-positive, choline-positive and FDG-positive ganglia was determined, the SUVmax of ganglia in different locations were measured, and the configuration was described. The SUVmax cutoff of PSMA-PET, choline-PET and FDG-PET was determined by ROC curve analysis to differentiate ganglia from LNM.

RESULTS

329 PSMA-positive ganglia were identified in 120 patients, 95 choline-positive ganglia were identified in 39 patients, and 39 FDG-positive ganglia were identified in 34 patients. PSMA-positive uptake was observed in 98.3%, 95.8%, and 80.0% of cervical, coeliac, and sacral ganglia, respectively. Choline-positive uptake was observed in 84.6%, 97.4%, and 61.5% of cervical, coeliac, and sacral ganglia, respectively. FDG-positive uptake was observed in 16.7%, 13.3%, and 2.5% of cervical, coeliac, and sacral ganglia, respectively. Cervical and coeliac ganglia had a higher rate of PSMA-positive uptake than sacral ganglia. Choline uptake was highest in coeliac ganglia followed by cervical and sacral ganglia. PSMA, choline or FDG uptake in LNM was all significantly higher than ganglia. ROC curve analysis revealed that at a 4.1 SUVmax cutoff of PSMA-PET, the sensitivity, specificity and accuracy of LNM identification was 88.4%, 97.9% and 96.2%, respectively. ROC curve analysis revealed that at a 2.35 SUVmax cutoff for choline-PET, the sensitivity, specificity, and accuracy of LNM identification was 95.0%, 92.6% and 93.0%, respectively. ROC curve analysis revealed that at a 2.55 SUVmax cutoff for FDG-PET, the sensitivity, specificity, and accuracy of LNM identification was 77.3%, 87.2%, and 81.9%, respectively. PSMA-, Choline- and FDG-positive ganglia are mainly band-shaped; most LNMs exhibited nodular and teardrop-shaped configuration.

CONCLUSION

Ga-PSMA and C-choline uptake in ganglia was common, and FDG-positive ganglia were observed at lower frequency. Using Ga-PSMA, C-choline and F-FDG uptake and anatomic location and configuration, the differentiation of ganglia from adjacent LNM is feasible.

摘要

目的

研究表明,PSMA阳性神经节是核医学医生诊断中的一个陷阱。尚无研究描述神经节中胆碱和FDG的摄取情况,这可能是误诊的一个来源。在此,我们描述了Ga-PSMA、C-胆碱和F-FDG PET/CT在神经节中的摄取百分比和模式,并评估了神经节的异质性代谢模式以与淋巴结转移(LNM)相鉴别。

方法

回顾性分析39例行C-胆碱PET/CT的患者以及120例行Ga-PSMA PET/CT和F-FDG PET/CT的患者。确定PSMA阳性、胆碱阳性和FDG阳性神经节的患病率,测量不同部位神经节的SUVmax,并描述其形态。通过ROC曲线分析确定PSMA-PET、胆碱-PET和FDG-PET的SUVmax临界值,以区分神经节和LNM。

结果

在120例患者中识别出329个PSMA阳性神经节,在39例患者中识别出95个胆碱阳性神经节,在34例患者中识别出39个FDG阳性神经节。PSMA阳性摄取分别在98.3%的颈神经节、95.8%的腹腔神经节和80.0%的骶神经节中观察到。胆碱阳性摄取分别在84.6%的颈神经节、97.4%的腹腔神经节和61.5%的骶神经节中观察到。FDG阳性摄取分别在16.7%的颈神经节、13.3%的腹腔神经节和2.5%的骶神经节中观察到。颈神经节和腹腔神经节的PSMA阳性摄取率高于骶神经节。胆碱摄取在腹腔神经节中最高,其次是颈神经节和骶神经节。LNM中PSMA、胆碱或FDG的摄取均显著高于神经节。ROC曲线分析显示,在PSMA-PET的SUVmax临界值为4.1时,LNM识别的敏感性、特异性和准确性分别为88.4%、97.9%和96.2%。ROC曲线分析显示,在胆碱-PET的SUVmax临界值为2.35时,LNM识别的敏感性、特异性和准确性分别为95.0%、92.6%和93.0%。ROC曲线分析显示,在FDG-PET的SUVmax临界值为2.55时,LNM识别的敏感性、特异性和准确性分别为77.3%、87.2%和81.9%。PSMA、胆碱和FDG阳性神经节主要呈带状;大多数LNM表现为结节状和泪滴状形态。

结论

神经节中Ga-PSMA和C-胆碱摄取常见,FDG阳性神经节观察频率较低。利用Ga-PSMA、C-胆碱和F-FDG摄取以及解剖位置和形态,区分神经节与相邻LNM是可行的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8103210/d1ac49ca81ad/fonc-11-666308-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8103210/b6a8df2c4296/fonc-11-666308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8103210/9890741546ac/fonc-11-666308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8103210/a8200b87a3f9/fonc-11-666308-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8103210/e772af8f43a8/fonc-11-666308-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8103210/03c80e062942/fonc-11-666308-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8103210/d1ac49ca81ad/fonc-11-666308-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8103210/b6a8df2c4296/fonc-11-666308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8103210/9890741546ac/fonc-11-666308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8103210/a8200b87a3f9/fonc-11-666308-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8103210/e772af8f43a8/fonc-11-666308-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8103210/03c80e062942/fonc-11-666308-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5b4/8103210/d1ac49ca81ad/fonc-11-666308-g006.jpg

相似文献

1
The Heterogeneous Metabolic Patterns of Ganglia in Ga-PSMA, C-choline, and F-FDG PET/CT in Prostate Cancer Patients.前列腺癌患者在镓-前列腺特异性膜抗原(Ga-PSMA)、碳-胆碱(C-choline)和氟-脱氧葡萄糖(F-FDG)PET/CT检查中神经节的异质性代谢模式
Front Oncol. 2021 Apr 23;11:666308. doi: 10.3389/fonc.2021.666308. eCollection 2021.
2
Use of Ga-PSMA-11 and F-FDG PET-CT Dual-Tracer to Differentiate Between Lymph Node Metastases and Ganglia.使用镓-PSMA-11和氟代脱氧葡萄糖PET-CT双示踪剂鉴别淋巴结转移与神经节
Front Oncol. 2021 Mar 10;11:646110. doi: 10.3389/fonc.2021.646110. eCollection 2021.
3
Ga-PSMA-HBED-CC Uptake in Cervical, Celiac, and Sacral Ganglia as an Important Pitfall in Prostate Cancer PET Imaging.镓-PSMA-HBED-CC 在颈、腹腔神经节和骶神经节的摄取是前列腺癌 PET 成像中的一个重要陷阱。
J Nucl Med. 2018 Sep;59(9):1406-1411. doi: 10.2967/jnumed.117.204677. Epub 2018 Jan 25.
4
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
5
Detection Rate of F-Choline PET/CT and Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes.F-胆碱 PET/CT 和 Ga-PSMA-HBED-CC PET/CT 对前列腺癌淋巴结转移的检出率:与 PET 到组织病理学的直接联系相关,取决于淋巴结中肿瘤沉积的大小。
J Nucl Med. 2019 Jul;60(7):971-977. doi: 10.2967/jnumed.118.220541. Epub 2019 Jan 25.
6
PSMA-1007 Uptake in Ganglia of the Sympathetic Trunk and Its Intra-individual Reproducibility.交感干神经节中 PSMA-1007 的摄取及其个体内的可重复性。
Mol Imaging Biol. 2023 Jun;25(3):554-559. doi: 10.1007/s11307-022-01784-4. Epub 2022 Nov 11.
7
Intra-Individual Comparison of Physiologic [Ga]Ga-PSMA-11 and [F]PSMA-1007 Uptake in Ganglia in Patients with Prostate Cancer: A Retrospective, Monocentric Analysis.前列腺癌患者神经节中生理性[镓]镓-PSMA-11与[氟]PSMA-1007摄取的个体内比较:一项回顾性单中心分析
Cancers (Basel). 2023 May 17;15(10):2787. doi: 10.3390/cancers15102787.
8
Establishment and prospective validation of an SUV cutoff value to discriminate clinically significant prostate cancer from benign prostate diseases in patients with suspected prostate cancer by Ga-PSMA PET/CT: a real-world study.应用 Ga-PSMA PET/CT 建立并前瞻性验证 SUV 截断值以鉴别疑似前列腺癌患者中由前列腺特异性膜抗原 PET/CT 检测的临床显著前列腺癌与良性前列腺疾病:一项真实世界研究。
Theranostics. 2021 Jul 25;11(17):8396-8411. doi: 10.7150/thno.58140. eCollection 2021.
9
[(68)Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice.[(68)Ga]PSMA-HBED 摄取模仿腹腔神经节淋巴结转移:临床实践中的一个重要陷阱。
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):210-4. doi: 10.1007/s00259-014-2915-3. Epub 2014 Sep 24.
10
Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer.18F-PSMA-1007与18F-FDG PET/CT在前列腺癌患者评估中的个体内比较
Front Oncol. 2021 Feb 1;10:585213. doi: 10.3389/fonc.2020.585213. eCollection 2020.

引用本文的文献

1
Diagnostic value of dual-tracer PET/CT with [F]FDG and PSMA ligands in prostate cancer: an updated systematic review.[F]FDG与前列腺特异性膜抗原(PSMA)配体双示踪剂PET/CT在前列腺癌中的诊断价值:一项更新的系统评价
Front Med (Lausanne). 2025 Jul 9;12:1607227. doi: 10.3389/fmed.2025.1607227. eCollection 2025.

本文引用的文献

1
Response to the Letter to the Editor: Prospective comparison of F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer.
Eur J Nucl Med Mol Imaging. 2021 Aug;48(9):2672-2673. doi: 10.1007/s00259-021-05428-7. Epub 2021 Jun 14.
2
Diagnostic Performance of F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study.F-DCFPyL-PET/CT 在生化复发前列腺癌男性患者中的诊断性能:来自 CONDOR Ⅲ期、多中心研究的结果。
Clin Cancer Res. 2021 Jul 1;27(13):3674-3682. doi: 10.1158/1078-0432.CCR-20-4573. Epub 2021 Feb 23.
3
Diagnostic Accuracy of F-PSMA-1007 PET/CT Imaging for Lymph Node Staging of Prostate Carcinoma in Primary and Biochemical Recurrence.F-PSMA-1007 PET/CT 成像在原发性和生化复发前列腺癌淋巴结分期中的诊断准确性。
J Nucl Med. 2021 Feb;62(2):208-213. doi: 10.2967/jnumed.120.246363. Epub 2020 Aug 17.
4
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought.根治性前列腺切除术后前列腺癌淋巴结复发行挽救性淋巴结清扫术的长期疗效:并不如先前认为的那样好。
Eur Urol. 2020 Nov;78(5):661-669. doi: 10.1016/j.eururo.2020.06.043. Epub 2020 Jul 2.
5
PSMA-targeted Radiotracers versus F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis.PSMA 靶向放射性示踪剂与 F 氟脱氧葡萄糖(18F-Fluciclovine)在明确治疗后前列腺癌生化复发检测中的比较:系统评价和荟萃分析。
Radiology. 2020 Jul;296(1):44-55. doi: 10.1148/radiol.2020191689. Epub 2020 May 12.
6
Impact of Ga-PSMA-11 PET on the Management of Recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.前瞻性单臂临床试验中 Ga-PSMA-11 PET 对复发性前列腺癌管理的影响。
J Nucl Med. 2020 Dec;61(12):1793-1799. doi: 10.2967/jnumed.120.242180. Epub 2020 May 1.
7
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
8
The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia.额外的晚期前列腺特异性膜抗原(PSMA)配体PET/CT在区分淋巴结转移和神经节中的作用
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):642-651. doi: 10.1007/s00259-019-04552-9. Epub 2019 Dec 21.
9
C-Choline PET/CT in Recurrent Prostate Cancer: Retrospective Analysis in a Large U.S. Patient Series.C-胆碱 PET/CT 在复发性前列腺癌中的应用:一项美国大样本患者系列的回顾性分析。
J Nucl Med. 2020 Jun;61(6):827-833. doi: 10.2967/jnumed.119.233098. Epub 2019 Dec 20.
10
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.镓 68 前列腺特异性膜抗原正电子发射断层扫描在晚期前列腺癌中的应用——更新的诊断效用、敏感性、特异性和前列腺特异性膜抗原阳性病变的分布:系统评价和荟萃分析。
Eur Urol. 2020 Apr;77(4):403-417. doi: 10.1016/j.eururo.2019.01.049. Epub 2019 Feb 14.